AbbVie Presents New Investigational Data for Elagolix at the 2018 American College of Obstetricians and Gynecologists (ACOG) Annual Meeting
Go back to AbbVie Presents New Investigational Data for Elagolix at the 2018 American College of Obstetricians and Gynecologists (ACOG) Annual Meeting| AbbVie (NYSE: ABBV) | Delayed: 233.88 +3.87 (1.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $230.01 | 52 Week High | $68.12 | |||
| Open | $232.97 | 52 Week Low | $50.71 | |||
| Day High | $234.71 | P/E | 50.73 | |||
| Day Low | $231.30 | EPS | $4.61 | |||
| Volume | 2,659,855 | |||||
| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 162.91 +1.29 (0.80%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $161.62 | 52 Week High | $58.46 | |||
| Open | $161.62 | 52 Week Low | $31.25 | |||
| Day High | $163.19 | P/E | N/A | |||
| Day Low | $161.35 | EPS | $-0.69 | |||
| Volume | 193,036 | |||||
